Hyperthermia Cancer Treatment Market Synopsis:
Hyperthermia Cancer Treatment Market Size Was Valued at USD 187.1 Million in 2023, and is Projected to Reach USD 284.1 Billion by 2032, Growing at a CAGR of 6.9% From 2024-2032.
The hyperthermia cancer treatment market is a relatively small but quickly growing subsegment of oncology, based on the application of heat to malignancies. This form of treatment is also known as fever therapy and takes benefit of heating tumor tissue to affect the cancer cells, and as a result exposes it to higher temperatures that increases its sensitivity to radiation treatment and chemotherapy. The aim of this treatment is to increase the potency of radiation therapy and chemotherapy making the tumor tissues better supplied with blood and oxygen. They are based on the principle of generating heat of controlled intensiveness that is lethal to cancer cells and causes their apoptosis and at the same time sparing the healthy cells.
The market for hyperthermia cancer treatment is revealing and more so now that studies show its efficacy in treating cancers that are refractory to other therapies. Being non-invasive and having fewer side effects than certain standard treatments of cancer, hyperthermia is slowly increasing its role as an additional therapy to traditional modalities. Furthermore, research shows that technology is creating better ways on how to manage temperature conduction and delivery hence enhanced treatment. The expanding client base due to the availability and consideration of other and additional procedures, including increase occurrences of cancer across the world help to advance the hyperthermia treatment needs.
However, the hyperthermia cancer treatment market is not without its problems: the high costs of the treatment to patients and lack of easily accessible specialized equipment and properly trained personnel to effectively deliver the therapy. Moreover, there exists low awareness of its existence and potentially limited and unstandardized therapeutic avenues. However, the market has more potential growth with continual clinical trial, the evolving acceptance by healthcare practitioners and with technological enhancements that make hyperthermia therapy more affordable and efficient. Due to the increasing trend toward individualized therapies and considering that hyperthermia is likely to form a cornerstone of cancer treatments in the future, it is possible to predict further growth of the market.
Hyperthermia Cancer Treatment Market Trend Analysis:
Integration of Hyperthermia with Immunotherapy and Targeted Therapies
- Another trend that can be observed on the hyperthermia cancer treatment market is the combined use of hyperthermia with immunotherapy and targeted therapies. Scientists and doctors believe that when hyperthermia is combined with other novel approaches to cancer therapy, they complement each other. Conjunctively used with immunotherapy, hyperthermia generates a stronger immune reaction owing to increased release of tumor antigen and better distribution of immune cells. Also, when together with targeted therapies, hyperthermia raises drug delivery to cancer cells, enhancing these therapies. This trend is creating new opportunities for repulsive and efficient orientation of oncology therapy that should stimulate the increased market growth.
Technological Advancements in Hyperthermia Equipment
- Another prominent trend in the market is the continuous technological advancements in hyperthermia equipment, making the treatment more precise and accessible. Innovations in devices such as radiofrequency and microwave hyperthermia applicators are enabling better control over temperature distribution, allowing for more effective and targeted treatment. Additionally, the development of portable and minimally invasive devices is making hyperthermia therapy more convenient and less expensive for healthcare providers and patients. As these technologies evolve, they will likely improve treatment outcomes, expand the range of cancers that can be treated, and contribute to the overall growth of the hyperthermia cancer treatment market.
Hyperthermia Cancer Treatment Market Segment Analysis:
Hyperthermia Cancer Treatment Market is Segmented on the basis of Source, application, and Region
By Treatment Type, Local Hyperthermia segment is expected to dominate the market during the forecast period
- The hyperthermia cancer treatment market is further divided into local, regional and whole body hyperthermia treatment. Local hyperthermia uses heat to directly attack the tumor sites, sometimes reached through external devices such as microwave or radio-frequency and is commonly used in skin, breast, or head and neck cancers. In regional hyperthermia a larger volume of tissue is heated for example an organ or appendage and is mainly applicable to lesion of deeper situs like organ based cancers abdominal or pelvic. Hyperthermia of the whole body involves a use of heating lamps to heat the body to a therapeutic level and it is usually used in metastatic cancer or when the cancer cells have spread to other parts of the body. Different kinds of treatment are used according to the place, size, and kind of cancer, and local hyperthermia is used the most often because it heats the respective parts of the tumor selectively.
By Application, Prostate Cancer segment expected to held the largest share
- The hyperthermia cancer treatment market is divided on the basis of application into prostate cancer, breast cancer, cervical cancer, skin cancer, and others. Hyperthermia therapy is known to have a positive effect in the management of different forms of cancer including when used alongside radiation and chemotherapy. In prostate cancer, hyperthermia is incorporated to boost the results of radiation treatment, since it helps to have more precise targets at tumors. With regard to breast and cervical carcinomas, hyperthermia is used to make the tumor more receptive to other treatments. Most skin cancer patients use localized hyperthermia to exclusively target shallow cancerous growths while in other cancer types including head and neck hyperthermia works as a supportive treatment. The following segmentation demonstrates the multifaceted use of hyperthermia in oncology and its increasing applicability to individual therapeutic strategies in various cancer subtypes.
Hyperthermia Cancer Treatment Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- The market for hyperthermia cancer treatment is estimated to grow at the highest CAGR in North America, due to factors such as well-established health care system in terms of facilities, services, and expenditure, and increase in interest on the development of new and innovative techniques for the treatment of cancer. A highly developed presence of leading pharmaceutical and research centers in the region is stimulating the creation of new hyperthermia technologies and treatment regimens. Also, a growing prevalence of cancer and the need for less invasive and efficient treatments is driving the hyperthermia adoption as a complementary treatment method. More funding in the clinical trials and high awareness as well as acceptance of the complementary therapies in cancer treatment along with the high investments in the clinical trials studies has put it in a very strategic position to continue leading the world in terms of hyperthermia cancer treatment market in North America.
Active Key Players in the Hyperthermia Cancer Treatment Market:
- MagForce AG (Germany)
- Andromedic S.r.l. (Italy)
- Celsius42 GmbH (Germany)
- Oncotherm Kft (Hungary)
- Pyrexar Medical (USA)
- YAMAMOTO VINITA CO., LTD (Japan)
- Nanoprobes (USA)
- Alba Hyperthermia System (Spain)
- Novavida (USA)
- Sensius (Netherlands)
- Other Active Players
|
Hyperthermia Cancer Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 187.1 Million |
|
Forecast Period 2024-32 CAGR: |
6.9% |
Market Size in 2032: |
USD 284.1 Million |
|
Segments Covered: |
By Treatment Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Hyperthermia Cancer Treatment Market by Treatment Type
4.1 Hyperthermia Cancer Treatment Market Snapshot and Growth Engine
4.2 Hyperthermia Cancer Treatment Market Overview
4.3 Local Hyperthermia
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Local Hyperthermia: Geographic Segmentation Analysis
4.4 Regional Hyperthermia
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Regional Hyperthermia: Geographic Segmentation Analysis
4.5 Whole Body Hyperthermia
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Whole Body Hyperthermia: Geographic Segmentation Analysis
Chapter 5: Hyperthermia Cancer Treatment Market by Application
5.1 Hyperthermia Cancer Treatment Market Snapshot and Growth Engine
5.2 Hyperthermia Cancer Treatment Market Overview
5.3 Prostate Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Prostate Cancer: Geographic Segmentation Analysis
5.4 Breast Cancer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Breast Cancer: Geographic Segmentation Analysis
5.5 Cervical Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Cervical Cancer: Geographic Segmentation Analysis
5.6 Skin Cancer
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Skin Cancer: Geographic Segmentation Analysis
5.7 Other Cancers
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Other Cancers: Geographic Segmentation Analysis
Chapter 6: Hyperthermia Cancer Treatment Market by End User
6.1 Hyperthermia Cancer Treatment Market Snapshot and Growth Engine
6.2 Hyperthermia Cancer Treatment Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinics: Geographic Segmentation Analysis
6.5 Specialty Centers
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Specialty Centers: Geographic Segmentation Analysis
6.6 Others (Academic and Research Institute)
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others (Academic and Research Institute): Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Hyperthermia Cancer Treatment Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 MAGFORCE AG (GERMANY)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 ANDROMEDIC S.R.L. (ITALY)
7.4 CELSIUS42 GMBH (GERMANY)
7.5 ONCOTHERM KFT (HUNGARY)
7.6 PYREXAR MEDICAL (USA)
7.7 YAMAMOTO VINITA CO. LTD (JAPAN)
7.8 NANOPROBES (USA)
7.9 ALBA HYPERTHERMIA SYSTEM (SPAIN)
7.10 NOVAVIDA (USA)
7.11 SENSIUS (NETHERLANDS) AND OTHER ACTIVE PLAYERS
Chapter 8: Global Hyperthermia Cancer Treatment Market By Region
8.1 Overview
8.2. North America Hyperthermia Cancer Treatment Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Treatment Type
8.2.4.1 Local Hyperthermia
8.2.4.2 Regional Hyperthermia
8.2.4.3 Whole Body Hyperthermia
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Prostate Cancer
8.2.5.2 Breast Cancer
8.2.5.3 Cervical Cancer
8.2.5.4 Skin Cancer
8.2.5.5 Other Cancers
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Clinics
8.2.6.3 Specialty Centers
8.2.6.4 Others (Academic and Research Institute)
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Hyperthermia Cancer Treatment Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Treatment Type
8.3.4.1 Local Hyperthermia
8.3.4.2 Regional Hyperthermia
8.3.4.3 Whole Body Hyperthermia
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Prostate Cancer
8.3.5.2 Breast Cancer
8.3.5.3 Cervical Cancer
8.3.5.4 Skin Cancer
8.3.5.5 Other Cancers
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Clinics
8.3.6.3 Specialty Centers
8.3.6.4 Others (Academic and Research Institute)
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Hyperthermia Cancer Treatment Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Treatment Type
8.4.4.1 Local Hyperthermia
8.4.4.2 Regional Hyperthermia
8.4.4.3 Whole Body Hyperthermia
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Prostate Cancer
8.4.5.2 Breast Cancer
8.4.5.3 Cervical Cancer
8.4.5.4 Skin Cancer
8.4.5.5 Other Cancers
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Clinics
8.4.6.3 Specialty Centers
8.4.6.4 Others (Academic and Research Institute)
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Hyperthermia Cancer Treatment Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Treatment Type
8.5.4.1 Local Hyperthermia
8.5.4.2 Regional Hyperthermia
8.5.4.3 Whole Body Hyperthermia
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Prostate Cancer
8.5.5.2 Breast Cancer
8.5.5.3 Cervical Cancer
8.5.5.4 Skin Cancer
8.5.5.5 Other Cancers
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Clinics
8.5.6.3 Specialty Centers
8.5.6.4 Others (Academic and Research Institute)
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Hyperthermia Cancer Treatment Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Treatment Type
8.6.4.1 Local Hyperthermia
8.6.4.2 Regional Hyperthermia
8.6.4.3 Whole Body Hyperthermia
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Prostate Cancer
8.6.5.2 Breast Cancer
8.6.5.3 Cervical Cancer
8.6.5.4 Skin Cancer
8.6.5.5 Other Cancers
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Clinics
8.6.6.3 Specialty Centers
8.6.6.4 Others (Academic and Research Institute)
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Hyperthermia Cancer Treatment Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Treatment Type
8.7.4.1 Local Hyperthermia
8.7.4.2 Regional Hyperthermia
8.7.4.3 Whole Body Hyperthermia
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Prostate Cancer
8.7.5.2 Breast Cancer
8.7.5.3 Cervical Cancer
8.7.5.4 Skin Cancer
8.7.5.5 Other Cancers
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Clinics
8.7.6.3 Specialty Centers
8.7.6.4 Others (Academic and Research Institute)
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Hyperthermia Cancer Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 187.1 Million |
|
Forecast Period 2024-32 CAGR: |
6.9% |
Market Size in 2032: |
USD 284.1 Million |
|
Segments Covered: |
By Treatment Type |
|
|
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
